Department of Hygiene and Public Health, Tokyo Women's Medical University, Tokyo, Japan.
Office for Global Relations, Nagasaki University, Nagasaki, Japan.
PLoS Negl Trop Dis. 2024 Jan 2;18(1):e0011854. doi: 10.1371/journal.pntd.0011854. eCollection 2024 Jan.
Little attention has been paid to neglected tropical diseases (NTDs) in high-income countries and no literature provides an overview of NTDs in Japan. This scoping review aims to synthesize the latest evidence and information to understand epidemiology of and public health response to NTDs in Japan. Using three academic databases, we retrieved articles that mentioned NTDs in Japan, written in English or Japanese, and published between 2010 and 2020. Websites of key public health institutions and medical societies were also explored. From these sources of information, we extracted data that were relevant to answering our research questions. Our findings revealed the transmission of alveolar echinococcosis, Buruli ulcer, Chagas disease, dengue, foodborne trematodiases, mycetoma, scabies, and soil-transmitted helminthiasis as well as occurrence of snakebites within Japan. Other NTDs, such as chikungunya, cystic echinococcosis, cysticercosis, leishmaniasis, leprosy, lymphatic filariasis, rabies, and schistosomiasis, have been imported into the country. Government agencies tend to organize surveillance and control programs only for the NTDs targeted by the Infectious Disease Control Law, namely, echinococcosis, rabies, dengue, and chikungunya. At least one laboratory offers diagnostic testing for each NTD except for dracunculiasis, human African trypanosomiasis, onchocerciasis, and yaws. No medicine is approved for treatment of Chagas disease and fascioliasis and only off-label use drugs are available for cysticercosis, opisthorchiasis, human African trypanosomiasis, onchocerciasis, schistosomiasis, and yaws. Based on these findings, we developed disease-specific recommendations. In addition, three policy issues are discussed, such as lack of legal frameworks to organize responses to some NTDs, overreliance on researchers to procure some NTD products, and unaffordability of unapproved NTD medicines. Japan should recognize the presence of NTDs within the country and need to address them as a national effort. The implications of our findings extend beyond Japan, emphasizing the need to study, recognize, and address NTDs even in high-income countries.
高收入国家对被忽视的热带病(NTDs)关注甚少,也没有文献对日本的 NTD 情况进行全面概述。本范围界定综述旨在综合最新证据和信息,了解日本 NTD 的流行病学和公共卫生应对措施。我们使用三个学术数据库检索了 2010 年至 2020 年间以英文或日文发表的、提到日本 NTD 的文章。还探索了关键公共卫生机构和医学协会的网站。从这些信息来源中,我们提取了与回答我们研究问题相关的数据。我们的研究结果表明,在日本有泡状棘球蚴病、布鲁里溃疡、恰加斯病、登革热、食源性吸虫病、真菌病、疥疮和土壤传播性蠕虫病的传播以及蛇咬伤的发生。其他 NTD,如基孔肯雅热、囊型包虫病、囊尾蚴病、利什曼病、麻风病、淋巴丝虫病、狂犬病和血吸虫病,已传入该国。政府机构往往只针对《传染病控制法》所针对的 NTD 组织监测和控制计划,即棘球蚴病、狂犬病、登革热和基孔肯雅热。除麦地那龙线虫病、非洲人类锥虫病、盘尾丝虫病和雅司病外,至少有一个实验室提供每种 NTD 的诊断检测。尚无治疗恰加斯病和片形吸虫病的药物批准,仅对囊尾蚴病、并殖吸虫病、非洲人类锥虫病、盘尾丝虫病、血吸虫病和雅司病可用非标签药物。根据这些发现,我们制定了针对特定疾病的建议。此外,还讨论了三个政策问题,例如缺乏组织应对某些 NTD 的法律框架、过度依赖研究人员获取某些 NTD 产品以及无法负担未经批准的 NTD 药物。日本应该认识到本国存在 NTD,并需要将其作为国家努力来解决。我们研究结果的意义超出了日本,强调即使在高收入国家也需要研究、认识和解决 NTD 问题。